Form 4 for TECH Bio-Techne
Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-06 · accession 0000914190-21-000215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-10 | 2021-08-08 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | F - Tax | $481.82 | -869 | 822 | -51% | -$418.7K |
| D | 2021-08-10 | 2021-08-08 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | +1,691 | 1,691 | New | $0 |
| D | 2021-08-10 | 2021-08-08 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | M - OptEx | $0.00 | -1,691 | 0 | -100% | $0 |
| DM | 2021-08-10 | 2021-08-06 | TECH | Kelderman Kim | Pres. Diagnostics, Genom | A - Grant | $0.00 | +12.6K | 6,486 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-08 | F | D | 869 | $481.82 | 822 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-08 | M | A | 1,691 | $0.00 | 1,691 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-08-08 | M | D | 1,691 | $0.00 | 0 | D | — · — to — | 1,691 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F4) Vested in full on 8/8/2021 upon the certification of achievement of performance goals. |
| 4 | Derivative | Restricted Stock Units | 2021-08-06 | A | A | 1,245 | $0.00 | 1,245 | D | — · — to — | 1,245 Common Stock | (F3) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F12) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| 5 | Derivative | Stock Options (Right to Buy) | 2021-08-06 | A | A | 4,864 | $0.00 | 4,864 | D | $481.82 · — to 2028-08-06 | 4,864 Common Stock | (F12) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| 6 | Derivative | Stock Options (Right to Buy) | 2021-08-06 | A | A | 6,486 | $0.00 | 6,486 | D | $481.82 · — to 2028-08-06 | 6,486 Common Stock | (F13) Options to purchase 1,622 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 1,621 shares vest on each of 8/6/2024 and 8/6/2025. |